 CHESTERBROOK, Pa., Sept. 17, 2021 GLOBE NEWSWIRE -- Trevena, Inc. Nasdaq: TRVN, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system CNS disorders, today announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the Oppenheimer 2021 Fall Healthcare Life Sciences MedTech Summit being held virtually from September 20th 23rd. 